GoodRx Statistics

Share Statistics

GoodRx has 351.45M shares outstanding. The number of shares has increased by -5.87% in one year.

Shares Outstanding	351.45M
Shares Change (YoY)	-5.87%
Shares Change (QoQ)	-6.89%
Owned by Institutions (%)	32.07%
Shares Floating	289.43M
Failed to Deliver (FTD) Shares	128,145
FTD / Avg. Volume	8.73%

Short Selling Information

The latest short interest is 5.52M, so 1.54% of the outstanding shares have been sold short.

Short Interest	5.52M
Short % of Shares Out	1.54%
Short % of Float	6.05%
Short Ratio (days to cover)	3.9

Valuation Ratios

The PE ratio is 109.44 and the forward PE ratio is 7.51. GoodRx's PEG ratio is -0.38.

PE Ratio	109.44
Forward PE	7.51
PS Ratio	2.26
Forward PS	1.4
PB Ratio	2.48
P/FCF Ratio	15.8
PEG Ratio	-0.38

Financial Ratio History

Enterprise Valuation

GoodRx has an Enterprise Value (EV) of 1.89B.

EV / Sales	2.38
EV / EBITDA	12.27
EV / EBIT	10.27
EV / FCF	16.63

Financial Position

The company has a current ratio of 5.32, with a Debt / Equity ratio of 0.75.

Current Ratio	5.32
Quick Ratio	5.32
Debt / Equity	0.75
Debt / EBITDA	3.53
Debt / FCF	4.79
Interest Coverage	1.24

Financial Efficiency

Return on Equity is 2.26% and Return on Invested Capital is 2.69%.

Return on Equity	2.26%
Return on Assets	1.18%
Return on Invested Capital	2.69%
Revenue Per Employee	$1.07M
Profits Per Employee	$22.21K
Employee Count	738
Asset Turnover	0.57
Inventory Turnover	n/a

Taxes

Income Tax	15.07M
Effective Tax Rate	47.9%

Stock Price Statistics

The stock price has increased by -48.53% in the last 52 weeks. The beta is 1.24, so GoodRx's price volatility has been higher than the market average.

Beta	1.24
52-Week Price Change	-48.53%
50-Day Moving Average	4.57
200-Day Moving Average	4.68
Relative Strength Index (RSI)	19.71
Average Volume (20 Days)	1,468,593

Income Statement

In the last 12 months, GoodRx had revenue of 792.32M and earned 16.39M in profits. Earnings per share was 0.04.

Revenue	792.32M
Gross Profit	744.11M
Operating Income	65.85M
Net Income	16.39M
EBITDA	153.92M
EBIT	84.38M
Earnings Per Share (EPS)	0.04

Full Income Statement

Balance Sheet

The company has 448.35M in cash and 543.39M in debt, giving a net cash position of -95.04M.

Cash & Cash Equivalents	448.35M
Total Debt	543.39M
Net Cash	-95.04M
Retained Earnings	-1.44B
Total Assets	1.32B
Working Capital	419.7M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 183.89M and capital expenditures -70.35M, giving a free cash flow of 113.55M.

Operating Cash Flow	183.89M
Capital Expenditures	-70.35M
Free Cash Flow	113.55M
FCF Per Share	0.29

Full Cash Flow Statement

Margins

Gross margin is 93.91%, with operating and profit margins of 8.31% and 2.07%.

Gross Margin	93.91%
Operating Margin	8.31%
Pretax Margin	3.97%
Profit Margin	2.07%
EBITDA Margin	19.43%
EBIT Margin	8.31%
FCF Margin	14.33%

Dividends & Yields

GDRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	0.91%
FCF Yield	6.33%

Dividend Details

Analyst Forecast

The average price target for GDRX is $6, which is 71.9% higher than the current price. The consensus rating is "Buy".

Price Target	$6
Price Target Difference	71.9%
Analyst Consensus	Buy
Analyst Count	9

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	1.34
Graham Upside	-61.6%

Scores

Altman Z-Score	0.78
Piotroski F-Score	8

GoodRx Inc. (GDRX)